NSF and Parkinson disease: The common LRRK2 mutation G2019S enhances NSF kinase activity, potentially disrupting SV dynamics through abnormal phosphorylation of NSF and contributing to the manifestation of Parkinson’s symptoms (Belluzzi et al., 2016).